Cartesian Growth Co. II (NASDAQ:RENE) Stock Price Up 0%

Cartesian Growth Co. II (NASDAQ:RENEGet Free Report) traded up 0% on Thursday . The stock traded as high as $11.21 and last traded at $11.19. 13,880 shares changed hands during mid-day trading, a decline of 76% from the average session volume of 57,110 shares. The stock had previously closed at $11.18.

Cartesian Growth Co. II Stock Down 0.0 %

The firm has a fifty day moving average price of $11.10 and a two-hundred day moving average price of $10.99.

Institutional Investors Weigh In On Cartesian Growth Co. II

Hedge funds and other institutional investors have recently modified their holdings of the business. Evercore Wealth Management LLC purchased a new stake in shares of Cartesian Growth Co. II in the fourth quarter worth approximately $120,000. Condor Capital Management purchased a new position in Cartesian Growth Co. II during the 4th quarter worth $201,000. Captrust Financial Advisors purchased a new position in Cartesian Growth Co. II during the 3rd quarter worth $194,000. XTX Topco Ltd purchased a new position in Cartesian Growth Co. II during the 2nd quarter worth $227,000. Finally, Barclays PLC purchased a new position in Cartesian Growth Co. II during the 2nd quarter worth $232,000. 58.96% of the stock is currently owned by hedge funds and other institutional investors.

Cartesian Growth Co. II Company Profile

(Get Free Report)

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.

Featured Stories

Receive News & Ratings for Cartesian Growth Co. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cartesian Growth Co. II and related companies with MarketBeat.com's FREE daily email newsletter.